Cervical cancer detection polypeptide and detection device and detection kit

Abstract

The present invention belongs to the technical field of immunoassay, and relates to a cervical cancer early diagnosis polypeptide composition and a detection device and a detection kit, the detection kit further comprises the detection device, the detection device comprises one or more solid carriers and the specific polypeptide composition independently connected with the more solid carriers, and the detection device and the detection kit can be used for early diagnosis and screening of cervical cancer.

Description

technical field [0001] The invention belongs to the field of biological detection, in particular to a polypeptide that can be used for early screening and clinical auxiliary diagnosis of cervical cancer, and a detection kit for a detection device containing the polypeptide. Background technique [0002] Antigen-antibody detection is a common detection method for immunoassay. A large number of studies have shown that tumor-associated antigens in serum or plasma can induce the body to produce autoantibodies, and there are both tumor antigens and white antibodies against the tumor antigens in the serum of many patients. Therefore, both antibodies can be used to detect tumor antigens, and antigens can also be used to detect tumor antigen autoantibodies, but the specificity and sensitivity of using tumor autoantibodies to detect tumors are much higher than using tumor antigens to detect tumors. Many tumor-associated antigens exist not only in tumor patients, but also in normal p...

AI Technical Summary

Problems solved by technology

However, the currently reported autoantibody detection methods have low sensitivity and poor specificity, and the false negative rate can be as high as 50%.

Images